Peizhi Zhou

996 total citations
64 papers, 675 citations indexed

About

Peizhi Zhou is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Surgery. According to data from OpenAlex, Peizhi Zhou has authored 64 papers receiving a total of 675 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Genetics and 20 papers in Surgery. Recurrent topics in Peizhi Zhou's work include Pituitary Gland Disorders and Treatments (26 papers), Glioma Diagnosis and Treatment (21 papers) and Meningioma and schwannoma management (11 papers). Peizhi Zhou is often cited by papers focused on Pituitary Gland Disorders and Treatments (26 papers), Glioma Diagnosis and Treatment (21 papers) and Meningioma and schwannoma management (11 papers). Peizhi Zhou collaborates with scholars based in China, United States and Russia. Peizhi Zhou's co-authors include Shu Jiang, Senlin Yin, Weichao Ma, Shizhen Zhang, Yu Hu, Liang Lv, Liang Lv, Yu Hu, Chao You and Mengmeng Wang and has published in prestigious journals such as Neurology, Scientific Reports and Journal of Controlled Release.

In The Last Decade

Peizhi Zhou

59 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peizhi Zhou China 17 264 196 182 177 161 64 675
Wiesław Bonicki Poland 13 334 1.3× 139 0.7× 95 0.5× 230 1.3× 143 0.9× 44 596
Giuseppe Catapano Italy 12 81 0.3× 180 0.9× 110 0.6× 122 0.7× 214 1.3× 38 578
Alexander F. Haddad United States 16 91 0.3× 254 1.3× 116 0.6× 231 1.3× 143 0.9× 71 797
Claudia Placidi Italy 14 269 1.0× 545 2.8× 244 1.3× 249 1.4× 109 0.7× 22 957
Mingxuan Xu United States 11 111 0.4× 158 0.8× 156 0.9× 99 0.6× 71 0.4× 24 555
Jean-François Vanbellinghen Belgium 10 110 0.4× 100 0.5× 149 0.8× 154 0.9× 81 0.5× 18 542
Hiromichi Nakabayashi Japan 15 78 0.3× 72 0.4× 206 1.1× 108 0.6× 99 0.6× 24 547
Shoichi Nagai Japan 15 60 0.2× 84 0.4× 228 1.3× 180 1.0× 140 0.9× 45 642
Song Liu China 15 106 0.4× 147 0.8× 141 0.8× 69 0.4× 43 0.3× 49 559
Liemei Guo China 14 66 0.3× 80 0.4× 348 1.9× 100 0.6× 100 0.6× 39 790

Countries citing papers authored by Peizhi Zhou

Since Specialization
Citations

This map shows the geographic impact of Peizhi Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peizhi Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peizhi Zhou more than expected).

Fields of papers citing papers by Peizhi Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peizhi Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peizhi Zhou. The network helps show where Peizhi Zhou may publish in the future.

Co-authorship network of co-authors of Peizhi Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Peizhi Zhou. A scholar is included among the top collaborators of Peizhi Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peizhi Zhou. Peizhi Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Yu, Yu Tang, Huiwen Tan, et al.. (2025). Cardiac structure and function recovery in acromegaly after treatment: insights from cardiac magnetic resonance imaging. Frontiers in Endocrinology. 16. 1630037–1630037.
3.
Shen, Ao, et al.. (2024). Different types of combined endoscopic and transcranial approaches for complex giant pituitary adenomas: how I do it. Acta Neurochirurgica. 166(1). 473–473. 1 indexed citations
4.
Jiang, Xiue, Huixin Tan, Wenbo He, et al.. (2024). Microgel-encapsulated tetrandrine nanoparticles promote spinal cord repair by sustaining neuroinflammation inhibition. Journal of Materials Chemistry B. 13(2). 683–694. 2 indexed citations
6.
Zhang, Shuheng, Xifeng Zhang, Hongyi Huang, et al.. (2023). Nanodelivery Systems as a Novel Strategy to Overcome Treatment Failure of Cancer. Small Methods. 8(1). e2301127–e2301127. 18 indexed citations
7.
He, Yihong, Yan Ju, Yuzhu Hu, et al.. (2023). Brd4 proteolysis-targeting chimera nanoparticles sensitized colorectal cancer chemotherapy. Journal of Controlled Release. 354. 155–166. 37 indexed citations
8.
Jiang, Yong, Weichao Ma, Haiyan Li, et al.. (2023). Single-cell sequencing of PIT1-positive pituitary adenoma highlights the pro-tumour microenvironment mediated by IFN-γ-induced tumour-associated fibroblasts remodelling. British Journal of Cancer. 128(6). 1117–1133. 19 indexed citations
9.
Zhong, Chuanhong, Lilei Peng, Bei Tao, et al.. (2022). TDO2 and tryptophan metabolites promote kynurenine/AhR signals to facilitate glioma progression and immunosuppression.. PubMed. 12(6). 2558–2575. 17 indexed citations
10.
Yin, Senlin, Yu Hu, Weichao Ma, et al.. (2020). Hyperprolactinemia in clinical non-functional pituitary macroadenomas. Medicine. 99(41). e22673–e22673. 11 indexed citations
11.
Hu, Yuzhu, Peizhi Zhou, Yunzhu Lin, Daoke Yang, & Bilan Wang. (2019). Anti-Colorectal Cancer Effect via Application of Polyethylene Glycol Modified Liposomal Apatinib. Journal of Biomedical Nanotechnology. 15(6). 1256–1266. 12 indexed citations
12.
Jiang, Yong, Liang Lv, Weichao Ma, et al.. (2019). Clinical features, radiological findings, and treatment outcomes of high-grade lateral ventricular meningiomas: a report of 26 cases. Neurosurgical Review. 43(2). 565–573. 8 indexed citations
13.
Lv, Liang, Yu Hu, Peizhi Zhou, et al.. (2018). Presurgical treatment with somatostatin analogues in growth hormone-secreting pituitary adenomas: A long-term single-center experience. Clinical Neurology and Neurosurgery. 167. 24–30. 18 indexed citations
14.
Zhou, Peizhi, Yue Cao, Xiaoxiao Liu, et al.. (2018). Delivery siRNA with a novel gene vector for glioma therapy by targeting Gli1. International Journal of Nanomedicine. Volume 13. 4781–4793. 10 indexed citations
15.
Sima, Xiutian, Hong Sun, Peizhi Zhou, Chao You, & Bowen Cai. (2017). Association between functional polymorphisms in the promoter of the miR-143/145 cluster and risk of intracranial aneurysm. Scientific Reports. 7(1). 43633–43633. 19 indexed citations
16.
Zhou, Peizhi, Senlin Yin, Shu Jiang, & Bowen Cai. (2015). Malignant intrasellar meningioma presenting as an invasive pituitary macroadenoma: A rare case report and literature review. Oncology Letters. 11(2). 1073–1076. 2 indexed citations
17.
Hu, Yu, Peizhi Zhou, Jiagang Liu, et al.. (2015). Cervical myelopathy caused by anomalies at the craniovertebral junction. The Spine Journal. 19(2). e2–e3. 1 indexed citations
18.
Sima, Xiutian, Hong Sun, Peizhi Zhou, & Chao You. (2015). A Potential Polymorphism in the Promoter of Let-7 is Associated With an Increased Risk of Intracranial Aneurysm. Medicine. 94(51). e2267–e2267. 15 indexed citations
19.
Zhong, Chuanhong, Senlin Yin, Peizhi Zhou, & Shu Jiang. (2014). Pituitary atypical adenoma or carcinoma sensitive to temozolomide combined with radiation therapy: a case report of early identification and management. Turkish Neurosurgery. 24(6). 963–6. 10 indexed citations
20.
Zhong, Weiying, Chao You, Shu Jiang, et al.. (2012). Symptomatic Rathke cleft cyst. Journal of Clinical Neuroscience. 19(4). 501–508. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026